Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-29 of 29 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Risk assessment and communication tools for genotype associations with multifactorial phenotypes: The concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyOzdemir, V.; Suarez-Kurtz, G.; Stenne, R.; Somogyi, A.; Someya, T.; Kayaalp, S.; Kolker, E.
2001The relationship between mood state and plasma methadone concentration in maintenance patientsDyer, K.; White, J.; Foster, D.; Bochner, F.; Menelaou, A.; Somogyi, A.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2000Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; Dyer, K.; White, J.; Bochner, F.
2004Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansGlaeser, H.; Drescher, S.; Hofmann, U.; Heinkele, G.; Somogyi, A.; Eichelbaum, M.; Fromm, M.
2004Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposureMitchell, T.; Dyer, K.; Newcombe, D.; Salter, A.; Somogyi, A.; Bochner, F.; White, J.
2007CYP2B6 CYP2D6 and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomesDavies, B.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2000Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatographyFoster, D.; Somogyi, A.; Bochner, F.